Trends in Cardiovascular Medicine
Volume 18, Issue 2 , Pages 61-66, February 2008

The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis

  • Mohamad Navab

      Affiliations

    • Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA
    • Corresponding Author InformationAddress correspondence to: Mohamad Navab, Room BH-307 CHS, Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, 10833, Le Conte Avenue, Los Angeles, CA 90095-1679, USA. Tel.: (+1) 310 206 2678; fax: (+1) 310 206 9133
    • ,
  • G.M. Anantharamaiah

      Affiliations

    • Department of Medicine, Atherosclerosis Research Unit, University of Alabama, Birmingham, Birmingham, AL 35294-0012, USA
    • ,
  • Alan M. Fogelman

      Affiliations

    • Division of Cardiology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA

Received 15 October 2007; received in revised form 14 December 2007; accepted 19 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 M. Navab, G. M. Anantharamaiah, and A. M. Fogelman are principals in Bruin Pharma (Los Angeles, CA).

PII: S1050-1738(08)00002-9

doi:10.1016/j.tcm.2007.12.006

Trends in Cardiovascular Medicine
Volume 18, Issue 2 , Pages 61-66, February 2008

Article Tools

* Image Usage & Resolution